| Trial ID: | L1317 |
| Source ID: | NCT05266794
|
| Associated Drug: |
Alpha Lipoic Acid
|
| Title: |
A Novel Role of Alpha Lipoic Acid in Comparison With Selenium in Mitochondrial Resuscitation and miRNA-126 Expression in Hemodialysis Patients
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Antioxidative Stress|End Stage Renal Disease on Dialysis
|
| Interventions: |
DRUG: Alpha lipoic acid|DRUG: Selenium
|
| Outcome Measures: |
Primary: Change in miRNA-126 level, Fold expression, 3 months|Change ROS level (ng/ml), Using ELISA kit, 3 months|Change in Co Q10 level (ng/ml), Using ELISA kit, 3 months |
|
| Sponsor/Collaborators: |
Sponsor: Ain Shams University
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
68
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
|
| Start Date: |
2019-01-22
|
| Completion Date: |
2019-04-30
|
| Results First Posted: |
|
| Last Update Posted: |
2022-03-04
|
| Locations: |
Ain Shams University, Cairo, 11566, Egypt
|
| URL: |
https://clinicaltrials.gov/show/NCT05266794
|